Annexes to the interim recommendations for use of the Janssen Ad26.COV2.S vaccine
6 June 2022
| COVID-19: Vaccines
Overview
These are the annexes to WHO interim recommendations for use of the Janssen Ad26.COV2.S vaccine against Covid-19. Annexes 1–6 contain tables that summarize the grading of recommendations, assessment, development and evaluations (GRADE). Annexes 7–9 contain the SAGE evidence-to-recommendation framework tables (ETR tables).
GRADE and ETR tables are updated as recommendations are updated.
This document has been updated: Version 6 June 2022.
Interim recommendations for use of the Janssen Ad26.COV2.S vaccine
Archived versions:
- Annexes to the interim guidance for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine. Version 9 December 2021.
- Annexes to the interim guidance for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine. Version 27 May 2021.
WHO Team
Immunization, Vaccines and Biologicals (IVB),
WHO Headquarters (HQ)
Editors
WHO
Number of pages
35
Reference numbers
WHO Reference Number: WHO-2019-nCoV-vaccines-SAGE-recommendation-Ad26.COV2.S-annexes-2022.1
Copyright
